Economic downturn takes toll on health of Americans with heart disease, diabetes or cancer

November 18, 2010

Boston, MA - A new poll from researchers at the Harvard School of Public Health (HSPH) and Knowledge Networks (KN) shows that many people with heart disease, diabetes or cancer believe the economic downturn is hurting their health and will have further negative impacts in the future. Many Americans with these illnesses face financial problems paying for medical bills in this economy. Most of these people do not believe the new national health care reform law (Patient Protection and Affordable Care Act 2010) will help them. This national poll is the first in a collaborative series of polls by HSPH and KN focused on people with heart disease, diabetes, or cancer; it was conducted October 27-31, 2010.

Many With Heart Disease, Diabetes or Cancer Say Economic Downturn Has Negative Impact on Their Health

More than a third of those with heart disease (35%) or diabetes (39%) say that the economic downturn has had a negative impact on their health, while more than a fifth of those with cancer (21%) say the same. An even greater share of people with each disease say the economic downturn will hurt their health in the future (47% of those with heart disease; 48% of those with diabetes; and 27% of those with cancer).

"Many people with heart disease, diabetes or cancer say the problems created by the economic downturn are spilling over into their physical health, not only today but also in the future," said Gillian K. SteelFisher, research scientist in the HSPH Department of Health Policy and Management and assistant director of the Harvard Opinion Research Program.

Economic Downturn Has Led Many with Heart Disease, Diabetes or Cancer into Financial Problems as They Try to Pay Medical Bills

Roughly a third of those with heart disease (35%) or diabetes (34%), and a fifth of those with cancer (22%) say the economic downturn has forced them to use up most or all of their savings in order to deal with medical bills, co-payments and other fees related to their illness. Between a fifth and a quarter of these groups have gone into credit card debt (25% of those with heart disease; 26% of those with diabetes; and 19% of those with cancer). Smaller percentages declared bankruptcy because of the economic downturn's impact on their ability to pay for medical care (4% of those with heart disease; 9% of those with diabetes; and 3% of those with cancer).

"While bankruptcy due to costs of health care has gotten national attention, it is also of serious concern that substantial proportions of people with these chronic conditions are depleting their savings and going into debt to pay for needed care," said Jordon Peugh, vice president of Health Care and Policy Research at Knowledge Networks.

Many Americans with Heart Disease, Diabetes or Cancer Say Economic Downturn Has Made it More Stressful to Manage Illness

Approximately 4 in 10 Americans with heart disease (43%) or diabetes (42%) and a fifth of those with cancer (21%) say the economic downturn has made it more stressful for them to manage their illness. As a result of the economic downturn, many of those with heart disease or diabetes also say they are cutting back on care from providers and regimens they follow at home to help manage their illness. For example, roughly a fifth of those with diabetes (19%) say they have skipped or delayed appointments with their doctor or nurse, and 15% say they have skipped or delayed recommended diagnostics or lab tests. At home, 18% of those with diabetes have not been able to follow the diet their provider recommended, and 23% say they are testing their blood sugar less often than they are supposed to. People with heart disease are cutting back to a similar degree, while those with cancer are less likely to be cutting back as a result of the economic downturn.

Most Americans with Heart Disease, Diabetes or Cancer Believe They Will Not be Better Off Under New National Health Care Reform Law

Less than 15% of people with heart disease, diabetes or cancer believe they will be better off under the new national health care reform law (14% of those with heart disease; 14% of those with diabetes and 11% of those with cancer). By comparison, approximately 4 in 10 believe they will be worse off under the new law (41% of those with heart disease; 38% of those with diabetes and 43% of those with cancer), and the remainder believe the law won't make much difference (34% of those with heart disease; 29% of those with diabetes; 38% of those with cancer) or don't know what the law's impact will be for them (11% of those with heart disease; 19% of those with diabetes; 8% of those with cancer).

"Although experts suggest the health care reform law has provisions that could help people with illnesses like heart disease, diabetes or cancer, many people who have such diseases do not believe it," said Professor Robert J. Blendon, director of the Harvard Opinion Research Program.


This poll is part of an on-going series of studies focused on the challenges of people with chronic illness by the Harvard Opinion Research Program (HORP) at Harvard School of Public Health (HSPH) and Knowledge Networks (KN). The research team includes Robert J. Blendon, Gillian K. SteelFisher, and Johanna R. Mailhot, of HSPH, and Jordon Peugh of KN. Interviews were conducted online for HORP by KN using KnowledgePanel®, a nationally representative panel of respondents recruited via traditional telephone and addressed-based sampling methods. People without computers or Internet access are given that technology for free when recruited onto the panel. From this panel, a sample of 508 people with heart disease, 506 people with diabetes, and 506 people with cancer participated. The margin of error at the 95% confidence level for respondents with each condition is plus or minus 6 percentage points. Data collection occurred October 27-31, 2010.

Possible sources of non-sampling error include non-response bias, as well as question wording and ordering effects. To compensate for these biases, for non-response, and probability of selection the initial sample is weighted to the US Census Bureau's Current Population Survey statistics benchmarks and the final data are weighted to National Health Interview Survey (2009) population statistics available from the Centers for Disease Control and Prevention for each disease condition. The weights adjust the sample for age, race, ethnicity, education, and region so as to be nationally representative of each of these conditions.
For more information:
Todd Datz
617 998 8819

Jordon Peugh
646 742 5334

Harvard School of Public Health ( ) is dedicated to advancing the public's health through learning, discovery, and communication. More than 400 faculty members are engaged in teaching and training the 1,000-plus student body in a broad spectrum of disciplines crucial to the health and well being of individuals and populations around the world. Programs and projects range from the molecular biology of AIDS vaccines to the epidemiology of cancer; from risk analysis to violence prevention; from maternal and children's health to quality of care measurement; from health care management to international health and human rights. For more information on the school, visit:

Knowledge Networks delivers quality and service to guide leaders in academia, government, and business - uniquely bringing scientifically valid research to the online space through its probability-based, online KnowledgePanel®. The company delivers unique study design, science, analysis, and panel maintenance, along with a commitment to close collaboration at every stage of the research process. Knowledge Networks leverages its expertise in health care, public policy, brands, media, and advertising to provide insights that speak directly to clients' most important concerns and research questions. For more information about Knowledge Networks, visit:

Harvard T.H. Chan School of Public Health

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to